Cargando…

Primary Debulking Surgery Versus Primary Neoadjuvant Chemotherapy for High Grade Advanced Stage Ovarian Cancer: Comparison of Survivals

BACKGROUND: The aim of the study was to analyze the overall survival (OS) and progression free survival (PFS) of patients with high grade and advanced stage epithelial ovarian cancer (EOC) with at least 60 months of follow-up treated in a single gynecologic oncology institute. We compared primary de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobal, Borut, Noventa, Marco, Cvjeticanin, Branko, Barbic, Matija, Meglic, Leon, Herzog, Marusa, Bordi, Giulia, Vitagliano, Amerigo, Saccardi, Carlo, Skof, Erik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137361/ https://www.ncbi.nlm.nih.gov/pubmed/30210049 http://dx.doi.org/10.2478/raon-2018-0030

Ejemplares similares

The role of neoadjuvant chemotherapy in patients with advanced (stage IIIC) epithelial ovarian cancer
por: Škof, Erik, et al.
Publicado: (2016)

Characteristics of Extracellular Vesicles from a High-Grade Serous Ovarian Cancer Cell Line Derived from a Platinum-Resistant Patient as a Potential Tool for Aiding the Prediction of Responses to Chemotherapy
por: Černe, Katarina, et al.
Publicado: (2023)

Application of Dynamic and Static Light Scattering for Size and Shape Characterization of Small Extracellular Nanoparticles in Plasma and Ascites of Ovarian Cancer Patients
por: Kogej, Ksenija, et al.
Publicado: (2021)

Vaginal-Laparoscopic Repair (VLR) of Primary and Persistent Vesico-Vaginal Fistula: Description of a New Technique and Surgical Outcomes
por: Tozzi, Roberto, et al.
Publicado: (2023)

Efficacy and safety of neoadjuvant chemotherapy versus primary debulking surgery in patients with ovarian cancer: a meta-analysis
por: Lv, Xiaofeng, et al.
Publicado: (2019)

The prognostic effect of residual tumor for advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy or primary debulking surgery
por: Yang, Shi‐Ping, et al.
Publicado: (2022)

Salpingectomy before assisted reproductive technologies: a systematic literature review
por: Noventa, Marco, et al.
Publicado: (2016)

Potential of Osteopontin in the Management of Epithelial Ovarian Cancer
por: Cerne, Katarina, et al.
Publicado: (2019)

Current Management of Polycystic Ovary Syndrome: From Bench to Bedside
por: Laganà, Antonio Simone, et al.
Publicado: (2018)

Neoadjuvant chemotherapy in ovarian, primary peritoneal and tubal carcinoma: can imaging results prior to interval debulking predict survival?
por: Menczer, Joseph, et al.
Publicado: (2011)

Comparison of Survival Between Primary Debulking Surgery Versus Neoadjuvant Chemotherapy for Ovarian Cancers in a Personalized Treatment Cohort
por: Feng, Zheng, et al.
Publicado: (2021)

Endometrial Cancer Risk Prediction According to Indication of Diagnostic Hysteroscopy in Post-Menopausal Women
por: Saccardi, Carlo, et al.
Publicado: (2020)

Residual tumor and primary debulking surgery vs interval debulking surgery in stage IV epithelial ovarian cancer
por: Sørensen, Sarah Mejer, et al.
Publicado: (2022)

Role of Neoadjuvant Chemotherapy in Ovarian Serous Cancer Followed by Debulking
por: Chauhan, Sonali, et al.
Publicado: (2022)

Cost-effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage IIIC and IV epithelial ovarian cancer
por: Forde, Gareth K, et al.
Publicado: (2016)

Neoadjuvant chemotherapy versus primary debulking surgery in advanced epithelial ovarian cancer: A meta-analysis of peri-operative outcome
por: Yang, Lijuan, et al.
Publicado: (2017)

Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer
por: Andrikopoulou, Angeliki, et al.
Publicado: (2023)

Interval debulking surgery is not worth the wait: a National Cancer Database study comparing primary cytoreductive surgery versus neoadjuvant chemotherapy
por: Lyons, Yasmin A, et al.
Publicado: (2020)

Primary debulking surgery for metastatic cervical adenocarcinoma: A case report
por: Davenport, Sara M., et al.
Publicado: (2015)

Primary Double Eyelid Surgery—Trapezoidal Debulking of Upper Eyelid Tissues
por: Chen, William P. D.
Publicado: (2018)

Factors associated with surgical morbidity of primary debulking in epithelial ovarian cancer
por: Günakan, Emre, et al.
Publicado: (2020)

Total parietal peritonectomy in primary debulking surgery for advanced ovarian cancer
por: Yokosu, Kota, et al.
Publicado: (2021)

Fertility-Sparing Approach in Women Affected by Stage I and Low-Grade Endometrial Carcinoma: An Updated Overview
por: Gullo, Giuseppe, et al.
Publicado: (2021)

Factors Predicting Use of Neoadjuvant Chemotherapy Compared With Primary Debulking Surgery in Advanced Stage Ovarian Cancer—A National Cancer Database Study
por: Leiserowitz, Gary S., et al.
Publicado: (2017)

Expression of Concern: Neoadjuvant chemotherapy versus primary debulking surgery in advanced epithelial ovarian cancer: A meta-analysis of peri-operative outcome
Publicado: (2023)

Hymen conservative techniques for vaginal surgery – a practical approach
por: Sleiman, Zaki, et al.
Publicado: (2022)

The effects of neoadjuvant chemotherapy and interval debulking surgery on body composition in patients with ovarian cancer
por: Vitarello, John, et al.
Publicado: (2021)

Primary pulmonary choriocarcinoma
por: Snoj, Ziga, et al.
Publicado: (2016)

Sildenafil Supplementation for Women Undergoing Infertility Treatments: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Marin, Loris, et al.
Publicado: (2021)

Neoadjuvant Chemotherapy Versus Primary Debulking Surgery in FIGO Stage III and IV Epithelial Ovarian, Tubal or Peritoneal Cancer: A Systematic Review and Meta-Analysis
por: Tzanis, Alexander A., et al.
Publicado: (2022)

Cervical Intraepithelial Neoplasia Grade 3 in a HPV-Vaccinated Patient: A Case Report
por: Sladič, Mateja, et al.
Publicado: (2022)

Upfront debulking surgery for high-grade serous ovarian carcinoma: current evidence
por: Tsonis, Orestis, et al.
Publicado: (2020)

Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery
por: Liu, Ying L., et al.
Publicado: (2019)

Three‐dimensional transvaginal ultrasound vs magnetic resonance imaging for preoperative staging of deep myometrial and cervical invasion in patients with endometrial cancer: systematic review and meta‐analysis
por: Spagnol, G., et al.
Publicado: (2022)

Imaging Modalities for Diagnosis of Deep Pelvic Endometriosis: Comparison between Trans-Vaginal Sonography, Rectal Endoscopy Sonography and Magnetic Resonance Imaging. A Head-to-Head Meta-Analysis
por: Noventa, Marco, et al.
Publicado: (2019)

Association between Endometrial Polyps and Chronic Endometritis: Is It Time for a Paradigm Shift in the Pathophysiology of Endometrial Polyps in Pre-Menopausal Women? Results of a Systematic Review and Meta-Analysis
por: Vitagliano, Amerigo, et al.
Publicado: (2021)

Mammographycally occult high grade ductal carcinoma in situ (DCIS) as second primary breast cancer, detected with MRI: a case report
por: Zebic-Sinkovec, Marta, et al.
Publicado: (2010)

Role of Renin-Angiotensin-Aldosterone System and Cortisol in Endometriosis: A Preliminary Report
por: Sabbadin, Chiara, et al.
Publicado: (2022)

Neoadjuvant chemotherapy followed by interval debulking surgery for advanced epithelial ovarian cancer: GOTIC-019 study
por: Nagao, Shoji, et al.
Publicado: (2023)

New Light on Endometrial Thickness as a Risk Factor of Cancer: What Do Clinicians Need to Know?
por: Saccardi, Carlo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_32ldb11k1k6dq0bqp0vlddv7po